Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times

被引:43
|
作者
Ashwell, SG [1 ]
Gebbie, J [1 ]
Home, PD [1 ]
机构
[1] Univ Newcastle Upon Tyne, Newcastle Diabet Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
glargine; insulin glargine; timing; Type; 1; diabetes;
D O I
10.1111/j.1464-5491.2005.01726.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To compare blood glucose control when insulin glargine is given at lunch-time, dinner-time, and bed-time in people with Type 1 diabetes using insulin lispro at meal-times. Methods In this 16-week, three-way, cross-over study, 23 people with Type 1 diabetes were randomized to insulin glargine injection at lunch-time (L) [mean 12.37 +/- 00.34 (+/- SD) h], dinner-time (D) (18.12 +/- 00.40 h), or bed-time (B) (22.29 +/- 00.40 h), each plus meal-time insulin lispro. Each 4-week treatment period concluded with a 24-h inpatient metabolic profile. Results Insulin doses, HbA(1c), and fructosamine concentration did not differ between treatment periods. Pre-breakfast self-monitored blood glucose (SMBG) concentration was higher with injection of glargine at lunch-time than at other times [L: 9.2 +/- 0.3 (+/- SE) vs. D: 8.2 +/- 0.3 or B: 8.0 +/- 0.3 mmol/l, P = 0.016], as probably was pre-lunch SMBG (L: 8.6 +/- 0.7 vs. D: 6.4 +/- 0.7 or B: 6.4 +/- 0.8 mmol/l, P = 0.051). Pre-dinner SMBG level was higher with dinner-time glargine than other injection times (D: 9.4 +/- 0.9 vs. L: 4.9 +/- 0.9 or B: 7.4 +/- 1.1 mmol/l, P = 0.007). For 22.00 to 02.00 h, mean inpatient plasma glucose concentration was higher with injection of glargine at bed-time than other times (B: 9.1 +/- 0.6 vs. L: 7.8 +/- 0.6 or D: 6.7 +/- 0.6 mmol/l, P = 0.023). Plasma free insulin concentration was lower at the end of the afternoon with dinner-time glargine than other injection times (D: 11.5 +/- 1.4 vs. L: 20.2 +/- 1.3 or B: 16.5 +/- 1.3 mU/l, P < 0.001). Frequency of hypoglycaemia was not different, but timing of hypoglycaemia differed between treatment periods. Conclusions Blood glucose levels rise around the time of injection of insulin glargine whether given at lunch-time, dinner-time or bed-time. Bed-time injection leads to hyperglycaemia in the early part of the night which is improved by giving insulin glargine at lunch-time or dinner-time.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [1] Optimal timing of injection of once-daily insulin glargine in people with type 1 diabetes using insulin lispro at meal-times
    Ashwell, SG
    Home, PD
    [J]. DIABETES, 2004, 53 : A118 - A118
  • [2] Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart
    Ashwell, SG
    Gebbie, J
    Home, PD
    [J]. DIABETES, 2005, 54 : A119 - A119
  • [3] Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
    Ashwell, S. G.
    Gebbie, J.
    Home, P. D.
    [J]. DIABETIC MEDICINE, 2006, 23 (08) : 879 - 886
  • [4] Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes A randomized open parallel multicenter study
    Bolli, Geremia B.
    Kerr, David
    Thomas, Reena
    Torlone, Elisabetta
    Sola-Gazagnes, Agnes
    Vitacolonna, Ester
    Selam, Jean Louis
    Home, Philip D.
    [J]. DIABETES CARE, 2009, 32 (07) : 1170 - 1176
  • [5] Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Zhou, Z.
    Cleall, S.
    Rodriguez, A.
    [J]. DIABETOLOGIA, 2013, 56 : S412 - S412
  • [6] Comparison of insulin glargine injection at lunchtime, dinner-time and bedtime in people with Type 1 diabetes using mealtime insulin lispro
    Ashwell, SG
    Gebbie, J
    Home, PD
    [J]. DIABETOLOGIA, 2004, 47 : A302 - A302
  • [7] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
    Bretzel, Reinhard G.
    Nuber, Ulrike
    Landgraf, Wolfgang
    Owens, David R.
    Bradley, Clare
    Linn, Thomas
    [J]. LANCET, 2008, 371 (9618): : 1073 - 1084
  • [8] Two phase 3 trials of 3-times weekly insulin degludec versus once-daily insulin glargine in insulin-naive people with type 2 diabetes
    DeVries, J. H.
    Ratner, R. E.
    Bode, B. W.
    Russell-Jones, D. L.
    Begtrup, K.
    Johansen, T.
    Zinman, B.
    [J]. DIABETOLOGIA, 2012, 55 : S21 - S22
  • [9] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Cleall, S.
    Rodriguez, A.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 963 - 970
  • [10] Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomized, open, parallel study
    Bolli, GB
    Capani, F
    Kerr, D
    Thomas, R
    Torlone, E
    Selam, JL
    Sola-Gazagnes, A
    Vitacolonna, E
    [J]. DIABETOLOGIA, 2004, 47 : A301 - A301